ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease:

Dementia Big
A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

http://ift.tt/2jnq9Xn